Company profile
Cardiac Biotech Solutions Inc.
OTC: CBSC · Healthcare · Medical - Instruments & Supplies
PublicHQ Las Vegas, CACIK 0001022183Reports USD
#1 of 1,418 Healthcare companies by revenue
EA Score
——FH —DQ —GM —SS 35
v0.1 · 5/100 weight · pillars only
↑ listing tenure, Piotroski F · ↓ workforce scale, Altman-Z
Methodology →Revenue TTM
$147.8k
Rev growth YoY (TTM)
+97.4%
Net income (FY)
—
Employees
4
as of 2026-08-24
Market cap
$6.3M
as of 2026-08-24
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
No filed financials — private or non-XBRL filer.
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Cardiac Biotech Solutions Inc.’s financial profile?
Cardiac Biotech Solutions Inc. has no structured financials on file — private or non-XBRL filer.
Peers · Healthcare
Curanex Pharmaceuticals Inc Common Stock——Imagion Biosystems Limited——Acurx Pharmaceuticals, Inc.——Kairos Pharma, Ltd.——Eastgate Biotech Corp.——CYduct Diagnostics, Inc.——Key facts
CEOCharles K. Martin
SectorHealthcare
IndustryMedical - Instruments & Supplies
HeadquartersLas Vegas, CA
ExchangeOTC: CBSC
Employees4
IPO date2016-02-16
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.